Finding Focus: ADHD Testing in Gilbert and East Valley

Living with ADHD can sometimes feel like navigating a maze, filled with distractions and challenges that make focus elusive. You might wondering, where can I find ADHD testing near me in Gilbert, Mesa, Chandler, or Queen Creek?

East Valley Psychiatric Services provides comprehensive, evidence-based ADHD testing and evaluation for children, adolescents, and adults in Gilbert and the surrounding East Valley communities. Our diagnostic process combines clinical interview and medical history with validated subjective rating scales (NICHQ Vanderbilt for children and the ASRS v1.1 for adults) and objective, FDA-cleared neurocognitive testing (QBCheck/QBTest).

ADHD Testing

Choosing East Valley Psychiatric Services for ADHD Testing

Clinical Expertise, Professional Credentials, and a Multidisciplinary Mindset

East Valley Psychiatric Services is led by a board-certified Psychiatric Mental Health Nurse Practitioner (PMHNP-BC) with training and experience diagnosing and treating ADHD across the lifespan. We integrate psychiatric expertise with a practical, patient-centered approach: conducting thorough interviews, reviewing medical and developmental history, screening for comorbid psychiatric or medical conditions, and interpreting objective test data. Our team emphasizes clear communication with patients, caregivers, schools, and other providers to ensure recommendations are realistic and actionable.

Evidence-Based, Multi-Modal Assessment to Improve Diagnostic Accuracy

ADHD symptoms often overlap with anxiety, depression, sleep disturbance, learning disorders, or situational stressors. To reduce diagnostic ambiguity, we combine three key elements:

  • Standardized subjective scales (NICHQ Vanderbilt for children; ASRS v1.1 for adults) to document symptom frequency and functional impairment across settings.
  • Objective, FDA-cleared testing with QBCheck/QBTest to quantify attention, impulsivity, and activity levels using validated computerized measures.
  • A structured clinical interview and medical review to assess onset, duration, developmental history, medical contributors, and rule out alternative explanations.

Combining subjective and objective data provides a more robust evidence base for diagnosis and informs precision in treatment selection and monitoring.

Safety-First Philosophy: In-Person Baseline Assessment

We require the initial appointment to be in-person so that vitals (blood pressure, heart rate) and weight can be accurately measured and documented. These baseline metrics are essential for safe medication prescribing and ongoing monitoring. The in-person visit also allows for a focused physical and neurological screen, observation of behavior in the clinic setting, and the opportunity to collect or review collateral information (school records, prior evaluations) when available.

Our ADHD Testing Process — Step-by-Step

Pre-Visit Intake and Records Collection

After scheduling, we provide secure new-patient paperwork including a detailed history form and rating scales to be completed by the patient and/or caregiver. We request any prior assessments, educational plans (IEP/504), past psychiatry or psychology records, and relevant medical documentation. Early submission of these materials shortens the in-person visit time and helps us prepare targeted questions.

In-Person Initial Evaluation — What Happens and Why It Matters

The initial evaluation typically lasts 60–90 minutes. Key components include:

  • Medical and psychiatric history review: onset of symptoms, developmental milestones, family psychiatric history, sleep, substance use, and medications.
  • Functional assessment: school/work performance, interpersonal relationships, activities of daily living, and the degree of impairment across settings.
  • Physical exam and vitals: weight, blood pressure, pulse, and targeted physical observations. These measurements are documented prior to any medication discussion and establish baselines for future monitoring.
  • Administration or ordering of objective testing: if QBCheck/QBTest is indicated, we will schedule the test during the visit or arrange a timely appointment at our clinic (or an authorized testing location) depending on patient age and practical considerations.
  • Review of completed rating scales: the clinician reviews Vanderbilt or ASRS responses with caregivers/adults to clarify specific items and contextual factors.

This thorough initial visit ensures safety, gathers reliable collateral information, and sets realistic expectations for diagnosis and treatment.

Objective Testing with QBCheck/QBTest — How It Adds Value

QBCheck/QBTest is an FDA-cleared, computerized assessment that measures core ADHD-related behaviors objectively: attention, impulse control, and activity levels. The test uses motion capture and response timing to generate quantitative scores that can be compared to age-matched norms. Key advantages include:

  • Objective data to supplement subjective reports, particularly useful when history is unclear or when symptoms fluctuate.
  • Quantifiable metrics that can show baseline symptom severity and track change over time with treatment.
  • Additional evidence to support school accommodations or workplace discussions when indicated.

We explain test purpose, procedure, and results in clear, non-technical language and integrate the findings with rating scale scores and clinical interview results.

Standardized Rating Scales — Vanderbilt & ASRS v1.1

Validated rating scales provide structured information about symptom frequency and functional impact in everyday settings:

  • NICHQ Vanderbilt Assessment: completed by caregivers and, when possible, teachers for children and adolescents. It covers inattention, hyperactivity/impulsivity, oppositional behaviors, and performance in school and social settings.
  • Adult ADHD Self-Report Scale (ASRS v1.1): a widely used screening tool that helps quantify adult inattentive and hyperactive symptoms and their impact on work and relationships.

These measures are best interpreted in combination with clinical interview and objective testing; they highlight symptom patterns across contexts and support diagnostic decisions and documentation for school or workplace accommodations.

Diagnostic Synthesis, Shared Decision-Making, and Treatment Planning

Within 1–2 weeks after the initial visit (sooner if urgent), we schedule a feedback session—typically 30–45 minutes—to discuss integrated findings. During this visit we:

  • Present results from the clinical interview, rating scales, and QBCheck/QBTest in an accessible format.
  • Provide a clear diagnostic statement (e.g., ADHD-combined presentation, ADHD-inattentive presentation, no ADHD; identify comorbid conditions if present).
  • Discuss evidence-based treatment options tailored to age, severity, comorbidity, patient preference, and safety considerations. Options may include behavioral interventions, psychotherapy referrals, lifestyle modifications (sleep hygiene, exercise, structure), school or work accommodations, and medication when indicated.
  • Create a follow-up plan specifying monitoring frequency, telehealth vs in-person visits, and criteria for medication initiation or adjustment.

We emphasize collaborative decision-making—addressing benefits, risks, expected timeline, and monitoring requirements—so patients and families can make informed choices.

Who We Evaluate — Age Groups, Common Presenting Problems, and Comorbidities

Children and Adolescents

We assess children and adolescents with concerns about attention, hyperactivity, impulsivity, academic decline, behavior problems, or social difficulties. The evaluation investigates symptom onset in early school years, cross-setting impairment (home and school), and developmental influences. We coordinate with parents, teachers, and schools as needed to obtain teacher rating scales and records and to help implement practical strategies and accommodations. For younger children, we place added emphasis on developmental history and environmental factors.

Adults

Adult presentations of ADHD often include chronic inattention, disorganization, time-management difficulties, workplace underperformance, relationship strain, and difficulties with executive functioning. Adults frequently have developed coping strategies that mask symptoms; objective testing combined with a careful developmental history helps determine whether symptoms are lifelong and meet diagnostic criteria. We also screen for comorbid mood, anxiety, substance use, and sleep disorders that can mimic or exacerbate ADHD.

Comorbidities and Differential Diagnosis

We screen for commonly co-occurring conditions—anxiety disorders, depressive disorders, learning disabilities, autism spectrum conditions, sleep disorders, and substance use—which can complicate diagnosis and treatment. QBCheck/QBTest and standardized scales help disentangle symptom sources, but clinical judgment and collateral history remain central to diagnosis.

In-Person vs Telehealth — Practical Considerations and Workflow

Why the First Visit Must Be In-Person

The initial in-person visit is required to obtain accurate vitals and weight measurements needed for safe ADHD medication prescribing and monitoring. In-person assessment allows for direct observation of behavior, performance on tasks, and rapport building—elements that enhance diagnostic accuracy and patient trust. It also ensures we meet best practice and medicolegal standards before initiating stimulant or other controlled medications.

Telehealth Follow-Ups for Medication Management and Monitoring

After the diagnostic synthesis and any initial medication decisions, many follow-up appointments can be conducted via secure telehealth. Telehealth follow-ups typically include symptom review, side-effect monitoring, dose adjustments, and functional assessment. Objective measures, such as repeat QBCheck/QBTest or in-office vitals, are scheduled as clinically necessary—often at intervals recommended by guidelines or sooner if concerns arise. Telehealth improves access and adherence while maintaining clinical oversight.

When In-Person Follow-Up Is Required

We request in-person follow-up when:

  • Medication initiation requires close monitoring of vitals or side effects.
  • Objective retesting is needed to assess response to treatment.
  • There are safety concerns, significant comorbidities, or unclear clinical response.
  • The patient or caregiver prefers in-person visits for evaluation or counseling.

Preparing for the Initial Visit — Practical Steps

What to Bring and How to Prepare

To maximize the value of the initial visit, please bring:

  • Photo ID and insurance card (if applicable).
  • A list of current medications and supplements.
  • Prior educational or psychiatric records (IEP, 504 plans, past evaluations).
  • Completed rating scales if provided in advance (caregiver and teacher forms for children).
  • A list of major concerns and questions.

We recommend arriving 5–10 minutes early to complete any outstanding forms. For children, having a parent or caregiver attend is essential; teachers may be asked to complete rating forms separately.

What to Expect on Test Day (QBCheck/QBTest)

QBCheck/QBTest administration takes approximately 20–45 minutes depending on the version and age. The patient completes computerized tasks while motion is recorded (in QBTest) or response patterns are measured (QBCheck). Testing is noninvasive and well tolerated by most patients; we provide clear instructions and support throughout. Results are scored against age norms and interpreted in conjunction with clinical context.

Insurance, Coverage, and Cost Considerations

Coverage for Evaluation and Testing

Coverage for ADHD evaluation, rating scales, and QBCheck/QBTest varies by insurer and plan. We recommend contacting your insurance prior to the visit to confirm benefits for psychiatric evaluation, psychological testing, and telehealth services. Our administrative staff can assist with benefit verification and provide estimates for out-of-pocket costs. We also offer self-pay options and transparent pricing for objective testing when insurance does not cover it.

Documentation for Schools and Work

We provide clear, clinician-signed documentation of diagnostic findings and treatment recommendations that can support school accommodations (IEP/504) or workplace accommodations when clinically appropriate. Objective QBCheck/QBTest results and standardized scale scores can strengthen requests for services or accommodations.

Monitoring, Outcomes, and Ongoing Care

Tracking Treatment Response with Objective and Subjective Measures

Objective testing (QBCheck/QBTest) can be repeated periodically to quantify symptom change and guide medication adjustments. Subjective measures (Vanderbilt, ASRS) and structured symptom checklists are used at follow-ups to assess functional improvement. We track side effects, adherence, and psychosocial outcomes and adjust treatment plans accordingly.

Coordinated Care and Referrals

When indicated, we coordinate care with pediatricians, primary care physicians, school teams, therapists, and specialists. Referrals for behavioral therapy, academic interventions, occupational therapy, or neuropsychological testing are made when appropriate. Our goal is to integrate pharmacologic and non-pharmacologic strategies for sustainable, real-world improvement.

Frequently Asked Questions (FAQ)

How does QBCheck/QBTest improve the evaluation?

QBCheck/QBTest provides objective, quantitative data on attention, impulse control, and activity that complements clinical interviews and rating scales. This is particularly helpful when histories are inconsistent, symptoms are subtle, or comorbid conditions complicate the picture.

Will my child or I always need medication?

Medication is one component of ADHD care and is recommended based on symptom severity, functional impairment, comorbidities, and patient/family preference. Many patients benefit from behavioral interventions, organizational supports, ADHD supplements, and lifestyle changes either alone or in combination with medication. We discuss all options and co-create a plan.

How soon will I get results?

We typically review and communicate results from the initial evaluation and any objective testing within 1–2 weeks. If testing is completed during the initial visit, we may provide preliminary feedback sooner.

Are telehealth appointments secure and effective?

We use secure, HIPAA-compliant telehealth platforms for follow-up care. Telehealth is effective for medication management, symptom review, and counseling coordination; objective testing and initial vital measurements, however, require in-person visits.

Can QBCheck/QBTest be used for monitoring medication effects?

Yes. Repeat QBCheck/QBTest assessments can quantify changes in attention and activity over time and can be a useful adjunct to clinical and subjective reports when evaluating response to medication.

Schedule an ADHD Evaluation at East Valley Psychiatric Services

How to Book and What to Expect Next

To schedule an in-person initial ADHD evaluation at our Gilbert office, call our office at 866-387-7924 or use the online booking portal. After scheduling, we will send new-patient forms and rating scales electronically and provide instructions for obtaining prior records. Remember: the initial visit is in-person to ensure safety; telehealth follow-ups are available thereafter. We welcome inquiries about insurance coverage, testing options, and the role of QBCheck/QBTest in your evaluation plan.

Our Commitment to Evidence, Safety, and Patient-Centered Care

At East Valley Psychiatric Services, we combine clinical expertise, validated rating scales, and FDA-cleared objective testing to deliver high-quality ADHD evaluations. Safety is central to our approach—starting with in-person baseline vital checks—and we prioritize clear communication, shared decision-making, and coordinated care to help patients and families achieve meaningful, measurable improvements in attention, functioning, and quality of life.

East Valley Psychiatric Services